Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation

• Main Authors: Lin Li (Author), Dongli Yang (Author), Jinghao Li (Author), Lu Niu (Author), Ye Chen (Author), Xin Zhao (Author), Patrick Kwabena Oduro (Author), Chun Wei (Author), Zongpei Xu (Author), Qilong Wang (Author), Yuhong Li (Author)
• Format: Book
• Published: BMC, 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Shenmai injection (SMI) has been used in the treatment of cardiovascular disease (CVD), such as heart failure, myocardial ischemia and coronary heart disease. It has been found to have efficacy on doxorubicin (DOX)-induced cardiomyopathy. The aims of this study were to explore th...